For citations:
Kondratyeva E.I., Odinaeva N.D., Repjeva E.V., Fatkhullina I.R., Sherman V.D. Efficacy and safety of triple therapy (elexacaftor/tezacaftor/ ivacaftor) in children with cystic fibrosis: 12-month follow-up. PULMONOLOGIYA. 2024;34(2):218-224. (In Russ.) https://doi.org/10.18093/0869-0189-2024-34-2-218-224